hubvision business intelligence inc.

5 hilltop lane
monsey, new york 10952

NYS Entity Status
ACTIVE

NYS Filing Date
JANUARY 16, 2014

NYS DOS ID#
4514747

County
ROCKLAND

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - HUBVISION BUSINESS INTELLIGENCE INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Food & Wine Magazine Will Leave New York for Alabama
    By STEPHANIE STROM - Friday Jun 23, 2017

    The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.

    Source: NYT > Home Page
  • Restaurant Review: Vegetables With Benefits at ABCV
    By PETE WELLS - Monday Jul 3, 2017

    The menu at Jean-Georges Vongerichten’s new vegetarian restaurant in the Flatiron district tries to impart “plant-based intelligence.”

    Source: NYT > Home Page
  • Instagram CEO Kevin Systrom on Free Speech, Artificial Intelligence, and Internet Addiction.
    By Nicholas Thompson - Thursday Aug 17, 2017

    Source: Webmonkey
  • Abbvie’s hep C drug pricing threatens Gilead’s dominance
    By Max Nisen - Tuesday Aug 8, 2017

    Pharma already leads the business world in unpredictability, with billions in sales potentially riding on a few points of statistical significance in a clinical trial.[...] even within that context, a series of blockbuster medicines for hepatitis C have made for a roller-coaster ride for companies and investors.AbbVie Inc. last week threw another big curve at this market by pricing its newly FDA-approved drug Mavyret — which might be the most effective hepatitis C medicine approved yet — at a massive discount.Medicines from Johnson & Johnson, Merck & Co. Inc. and Vertex Pharmaceuticals Inc. approved within the past six years, which once booked billions in combined sales, are now essentially non-factors.After offering behind-the-scene discounts to insurance companies, pharmacy benefit managers and other payers, Mavyret’s price is actually not far from Harvoni’s, according to Bloomberg Intelligence.The real headache for Gilead — which already faces steep declines in hepatitis C drug sales because of increasing competition and the fact that many patients have been cured — lies in the fact that not all hepatitis patients or medicines are the same.AbbVie’s new drug can treat all of the major subtypes of hepatitis C. And it can cure the disease in many patients in just eight weeks.

    Source: SFGATE.com: Business and Technology News
  • Facebook Will Use Artificial Intelligence to Find Extremist Posts
    By SHEERA FRENKEL - Thursday Jun 15, 2017

    Under pressure from governments to counter inappropriate content, the social media company will pair new technology with human moderators.

    Source: NYT > Home Page
  • Emotional Intelligence: Tech’s Damaging Myth of the Loner Genius Nerd
    By CLAIRE CAIN MILLER - Saturday Aug 12, 2017

    In truth, interpersonal skills like collaboration, communication and empathy are vital to career success in technology.

    Source: NYT > Home Page
hubvision business intelligence inc monsey ny